Search

Search Constraints

You searched for: Author/Creator Rickenbacher, Peter

Search Results

1. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Issue 10150 (8th September 2018)

2. Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2. Issue 5 (10th May 2018)

3. Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF). (15th March 2017)

4. Impact of worsening renal function related to medication in heart failure. (30th December 2014)

5. Interaction of Galectin-3 Concentrations with the Treatment Effects of β-Blockers and RAS Blockade in Patients with Systolic Heart Failure: A Derivation-Validation Study from TIME-CHF and GISSI-HF. (6th January 2020)

6. Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents. Issue 1 (6th January 2015)

7. Long-Term Efficacy and Safety of Biodegradable-Polymer Biolimus-Eluting Stents: Main Results of the Basel Stent Kosten-Effektivitäts Trial–PROspective Validation Examination II (BASKET-PROVE II), A Randomized, Controlled Noninferiority 2-Year Outcome Trial. Issue 1 (6th January 2015)

8. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Issue 10261 (7th November 2020)

9. N‐terminal pro brain natriuretic peptide‐guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF). (October 2013)

10. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2. (February 2022)